Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR T-Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05364424
What this trial is testing

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Hoffmann-La Roche 43
Very early researchUnknownNCT05239676
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Who this might be right for
Lymphoma
Zhejiang University 50
Not applicableLooking for participantsNCT06343090
What this trial is testing

Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia
Beijing GoBroad Hospital 353
Early research (Phase 1)Active Not RecruitingNCT02663297
What this trial is testing

Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

Who this might be right for
Hodgkin DiseaseLymphomaLymphoma, Non-Hodgkin+6 more
UNC Lineberger Comprehensive Cancer Center 18
Not applicableLooking for participantsNCT06581081
What this trial is testing

Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Adult ALLB-cell Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia+1 more
Peking University People's Hospital 130
Early research (Phase 1)Temporarily pausedNCT06197672
What this trial is testing

Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Huda Salman 30
Early research (Phase 1)Not Yet RecruitingNCT06913192
What this trial is testing

Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 50
Testing effectiveness (Phase 2)Study completedNCT07236151
What this trial is testing

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

Who this might be right for
Large B-cell LymphomaCAR T Cell TherapyAuto Stem Cell Transplant
The First Affiliated Hospital of Soochow University 23
Not applicableUnknownNCT04336501
What this trial is testing

Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation

Who this might be right for
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd. 20
Not applicableUnknownNCT05190653
What this trial is testing

Early Integration of Palliative and Supportive Care in Cellular Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alberta Health Services, Calgary 152
Not applicableLooking for participantsNCT07059741
What this trial is testing

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University 20
Not applicableStudy completedNCT05180838
What this trial is testing

Remote Temperature Data for Early Detection of Febrile Neutropenia

Who this might be right for
Hematologic Malignancy
University of Colorado, Denver 20
Not applicableLooking for participantsNCT04691284
What this trial is testing

Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation

Who this might be right for
Hematologic Neoplasms
National Cancer Institute, Slovakia 100
Early research (Phase 1)Study completedNCT02659943
What this trial is testing

T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies

Who this might be right for
Lymphoma, B-CellLymphoma, Non-hodgkins
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT04923789
What this trial is testing

ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06646666
What this trial is testing

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Who this might be right for
B-cell Non Hodgkin Lymphoma
Ruijin Hospital 35
Not applicableStudy completedNCT05826288
What this trial is testing

Oncology Care at Home for BMT and CAR-T

Who this might be right for
Leukemia
University of Colorado, Denver 11
Not applicableUnknownNCT05576220
What this trial is testing

Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy

Who this might be right for
Febrile Neutropenia
IDION Inc. 210
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 200
Next Page